These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 36718258)

  • 1. COVID-19 vaccine equity in doldrums: Good governance deficits.
    Bhuiyan S
    Public Adm Dev; 2022 Dec; 42(5):293-304. PubMed ID: 36718258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Global vaccine inequities and multilateralism amid COVID-19: Reconnaissance of Global Health Diplomacy as a panacea?
    Singh B; Kaur J; Chattu VK
    Health Promot Perspect; 2022; 12(4):315-324. PubMed ID: 36852205
    [No Abstract]   [Full Text] [Related]  

  • 3. Redressing COVID-19 vaccine inequity amidst booster doses: charting a bold path for global health solidarity, together.
    Rackimuthu S; Narain K; Lal A; Nawaz FA; Mohanan P; Essar MY; Charles Ashworth H
    Global Health; 2022 Feb; 18(1):23. PubMed ID: 35193616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-country evidence on the role of national governance in boosting COVID-19 vaccination.
    Aida T; Shoji M
    BMC Public Health; 2022 Mar; 22(1):576. PubMed ID: 35321676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19 vaccine equity: a health systems and policy perspective.
    Van De Pas R; Widdowson MA; Ravinetto R; N Srinivas P; Ochoa TJ; Fofana TO; Van Damme W
    Expert Rev Vaccines; 2022 Jan; 21(1):25-36. PubMed ID: 34758678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Global health governance performance during Covid-19, what needs to be changed? a delphi survey study.
    Abu El Kheir-Mataria W; El-Fawal H; Chun S
    Global Health; 2023 Mar; 19(1):24. PubMed ID: 37004079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Dilemma, causes and countermeasures of global health governance: taking COVID-19 Vaccines Global Access Facility as an example].
    Bai AY; Zhang B; Jiang Y; Qiao Y
    Zhonghua Liu Xing Bing Xue Za Zhi; 2022 Apr; 43(4):483-487. PubMed ID: 35443301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. State capture through indemnification demands? Effects on equity in the global distribution of COVID-19 vaccines.
    Gorodensky A; Kohler JC
    J Pharm Policy Pract; 2022 Aug; 15(1):50. PubMed ID: 35986397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ensuring the global COVID-19 vaccine equity: Universal vaccine access strategy in the context of low and-middle-income countries.
    Parray AA; Yadav UN; Das A; Ali AM; Mollick S; Saha S; Mistry SK
    Glob Public Health; 2022 Apr; 17(4):614-621. PubMed ID: 35050840
    [No Abstract]   [Full Text] [Related]  

  • 10. The Race for Global Equitable Access to COVID-19 Vaccines.
    Md Khairi LNH; Fahrni ML; Lazzarino AI
    Vaccines (Basel); 2022 Aug; 10(8):. PubMed ID: 36016194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attributes of national governance for an effective response to public health emergencies: Lessons from the response to the COVID-19 pandemic.
    Assefa Y; Woldeyohannes S; Cullerton K; Gilks CF; Reid S; Van Damme W
    J Glob Health; 2022 Jul; 12():05021. PubMed ID: 35787525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risky business: COVAX and the financialization of global vaccine equity.
    Stein F
    Global Health; 2021 Sep; 17(1):112. PubMed ID: 34544439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Supporting the pandemic response and timely access to COVID-19 vaccines: a case for stronger priority setting and health system governance in Nigeria.
    Chukwu OA; Kapiriri L; Essue B
    Int J Pharm Pract; 2022 Jun; 30(3):284-287. PubMed ID: 35468198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of good governance in the race for global vaccination during the COVID-19 pandemic.
    Tatar M; Faraji MR; Montazeri Shoorekchali J; Pagán JA; Wilson FA
    Sci Rep; 2021 Nov; 11(1):22440. PubMed ID: 34789826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. International Collaboration to Ensure Equitable Access to Vaccines for COVID-19: The ACT-Accelerator and the COVAX Facility.
    Eccleston-Turner M; Upton H
    Milbank Q; 2021 Jun; 99(2):426-449. PubMed ID: 33650737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pro-poor governance in water and sanitation service delivery: evidence from Global Analysis and Assessment of Sanitation and Drinking Water surveys.
    Fuente D; Bartram J
    Perspect Public Health; 2018 Sep; 138(5):261-269. PubMed ID: 30015570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determinants of access to the SARS-CoV-2 vaccine: a preliminary approach.
    de Oliveira BRB; da Penha Sobral AIG; Marinho MLM; Sobral MFF; de Souza Melo A; Duarte GB
    Int J Equity Health; 2021 Aug; 20(1):183. PubMed ID: 34391416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Global public health security and justice for vaccines and therapeutics in the COVID-19 pandemic.
    Hotez PJ; Batista C; Amor YB; Ergonul O; Figueroa JP; Gilbert S; Gursel M; Hassanain M; Kang G; Kaslow DC; Kim JH; Lall B; Larson H; Naniche D; Sheahan T; Shoham S; Wilder-Smith A; Sow SO; Strub-Wourgaft N; Yadav P; Bottazzi ME
    EClinicalMedicine; 2021 Sep; 39():101053. PubMed ID: 34368661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is COVID-19 vaccine inequality undermining the recovery from the COVID-19 pandemic?
    Suárez-Álvarez A; López-Menéndez AJ
    J Glob Health; 2022 May; 12():05020. PubMed ID: 35604879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing Inequities in COVID-19 Vaccine Roll-Out Strategy Programs: A Cross-Country Study Using a Machine Learning Approach.
    Kazemi M; Bragazzi NL; Kong JD
    Vaccines (Basel); 2022 Jan; 10(2):. PubMed ID: 35214653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.